Now, attention is shifting somewhere far more unexpected.
New research suggests that a common oral bacterium, better known for causing tooth decay, may quietly travel from the mouth to the gut, produce toxic compounds and then help set off the chain of damage that ends in Parkinson’s disease.
A familiar dental bacterium under suspicion
Parkinson’s disease has long been classed as a strictly neurological disorder, driven by the slow loss of dopamine-producing nerve cells deep in the brain. Yet a growing body of evidence points toward a different starting point: the microbiome, especially in the gut, and now possibly the mouth.
In a recent study reported in 2025 in the journal Nature Communications, scientists focused on a bacterium called Streptococcus mutans. Dentists know it well: it’s one of the main culprits behind tooth decay. What surprised researchers is how often this microbe shows up in the intestines of people with Parkinson’s, compared with those without the condition.
Researchers found that a common cavity-causing bacterium can migrate from the mouth to the gut and may help drive changes linked to Parkinson’s disease.
Instead of staying confined to the mouth, S. mutans appears able to travel down the digestive tract and settle into the gut microbiome. Once there, it does more than just live quietly alongside other microbes. It starts manufacturing specific substances that can leave the intestine, circulate in the bloodstream and ultimately reach the brain.
From mouth to gut to brain: a new disease pathway
The study adds weight to the idea of a “mouth–gut–brain axis” in Parkinson’s. The chain begins with the colonisation of the gut by S. mutans. After it settles, the bacterium produces a particular enzyme. That enzyme then drives the formation of a small molecule called imidazole propionate.
Imidazole propionate does not simply stay in the gut. It passes into the blood and crosses the blood–brain barrier, the protective wall of cells that normally keeps many toxins out of the brain.
Once inside the brain, the bacterial metabolite imidazole propionate appears to interfere with key pathways that keep neurons alive and functioning.
In animal experiments, exposure to this molecule led to several hallmark features of Parkinson’s:
➡️ 13 Photos Of Cats And Dogs To Help You Start The Year On The Right Foot
➡️ Strange Red Rocks in Australia Are Challenging Long-Held Ideas About Fossils
➡️ Do you always wake up between 2 and 4 a.m.? This hormone may be to blame
➡️ How often can you dye your hair without damaging it?
- progressive loss of dopamine-producing neurons
- increased inflammation in brain tissue
- abnormal accumulation of alpha-synuclein, a protein that clumps in Parkinson’s
- worsening motor performance over time
These changes mirror what neurologists see in the brains of people living with Parkinson’s. The findings suggest that in some individuals, the presence of certain bacteria and their byproducts could accelerate damage that might otherwise unfold more slowly.
How a bacterial molecule hijacks brain signalling
The key mechanism identified in the study involves a signalling pathway inside cells called mTORC1. This pathway acts a bit like a thermostat for growth and survival signals. It helps neurons manage energy use, protein production and stress.
Imidazole propionate appears to push mTORC1 into overdrive. When the pathway is chronically overactivated, neurons become more vulnerable. They clear damaged proteins less efficiently, accumulate waste and eventually die more readily under stress.
In the animal models used by the team, drugs that blocked mTORC1 activity reduced brain lesions and helped preserve movement. That finding hints at a double strategy for future therapies: targeting both the bacterial source in the gut and the signalling pathway inside the brain.
What this could mean for early stages of Parkinson’s
One of the puzzles in Parkinson’s is that many subtle changes appear in the body long before tremors or stiffness start. Constipation, changes in smell and sleep disturbances can precede diagnosis by years.
The mouth–gut–brain axis provides a plausible explanation. If a bacterium like S. mutans colonises the gut early, it could quietly release imidazole propionate for years. During that time, neurons in key brain areas might be slowly damaged, without obvious symptoms.
This model supports the idea that Parkinson’s may begin outside the brain, with pathological changes building up long before classic motor signs appear.
Could brushing your teeth help protect your brain?
Researchers emphasise that S. mutans is not the sole cause of Parkinson’s. Genetics, age, environmental exposures and other microbes all play roles. Still, the new data put oral health firmly on the list of factors worth watching.
The bacterium’s main known habitat is the mouth, especially in sticky dental plaque. When oral hygiene is poor, its levels rise. That raises the chance of both tooth decay and, potentially, migration towards the gut.
Certain habits may help keep S. mutans in check:
- brushing teeth at least twice a day with fluoride toothpaste
- cleaning between teeth with floss or interdental brushes
- limiting frequent sugary snacks and drinks, which feed the bacterium
- seeing a dentist regularly for professional cleaning and early treatment of cavities
None of these steps guarantees protection against Parkinson’s, but they may lower exposure to one possible trigger while improving overall health.
New therapeutic avenues targeting the microbiome
The findings reinforce a broader shift in neurology: the idea that the gut microbiome can influence brain diseases. If specific bacteria and their metabolic products contribute to Parkinson’s, they might also become targets for treatment or prevention.
| Potential strategy | Goal |
|---|---|
| Reduce S. mutans in the mouth | Lower the chance of gut colonisation and metabolite production |
| Modify gut microbiome (diet, probiotics, future drugs) | Shift the microbial balance away from harmful species |
| Block imidazole propionate production or action | Prevent the bacterial metabolite from reaching or harming the brain |
| Target mTORC1 signalling in neurons | Protect dopamine-producing cells from stress and degeneration |
Most of these ideas remain at an early research stage. Large human studies will be needed to see whether people with high levels of S. mutans or imidazole propionate face a higher risk of Parkinson’s, and whether changing the microbiome can actually alter that risk.
Key terms readers often ask about
Microbiome: the vast community of bacteria, viruses and fungi that live in and on the human body, especially in the gut. These organisms help digest food, train the immune system and produce a variety of molecules that can influence health.
Alpha-synuclein: a protein found in many brain cells. In Parkinson’s, it tends to misfold and form clumps called Lewy bodies. These clumps are closely linked to neuron death.
Dopamine-producing neurons: nerve cells that make the chemical messenger dopamine. They are heavily involved in controlling movement. Their gradual loss is a defining feature of Parkinson’s disease.
mTORC1 pathway: a key biochemical route inside cells that regulates growth, metabolism and survival. Healthy levels of activity support normal function; chronic overactivation can promote cellular stress and degeneration.
What this research means in everyday life
For someone with a family history of Parkinson’s, this line of research suggests a few practical steps. Good oral hygiene and regular dental check-ups become not just about saving teeth but potentially about limiting unnecessary bacterial stress on the brain. Paying attention to gut health — with a fibre-rich diet, reduced ultra-processed foods and cautious use of antibiotics — may also help maintain a balanced microbiome.
Clinicians are starting to imagine future screening tools that measure certain bacterial metabolites, including imidazole propionate, in blood samples. If these markers reliably flag higher risk years before symptoms, they could open a window for early interventions aimed at the mouth and gut, long before irreversible brain damage sets in.
For now, the message is nuanced: Parkinson’s remains a complex disorder with many contributing factors, but the humble cavity bacterium Streptococcus mutans has unexpectedly joined the shortlist of suspects that might help tip a vulnerable brain towards disease.